Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2-Apr-2024
2024 EGM Notice of Meeting and Proxy
28-Mar-2024
Nyrada Commences Key Brain Injury Program Preclinical Study
15-Mar-2024
Notice of Change of Interests of Substantial Securityholder
15-Mar-2024
Notice of Change of Interests of Substantial Securityholder
15-Mar-2024
Cleansing Statement
15-Mar-2024
Application for quotation of securities - NYR
15-Mar-2024
Amended and Restated Certificate of Incorporation and Bylaw
14-Mar-2024
Change of Director's Interest Notice - CC
14-Mar-2024
Change of Director's Interest Notice - RW
14-Mar-2024
Change of Director's Interest Notice - MF
Previous
1
2
3
4
5
6
7
8
Next